Search results
New nasal Covid-19 vaccine trial kicks off in US
India Today· 4 days agoThe clinical trial of an experimental nasal vaccine designed to protect against new variants of SARS-CoV-2, the virus that causes Covid-19</ ...
GSK takes full rights to COVID-19, influenza vaccines from CureVac
Financial Express· 3 days agoThe partnership began in 2020 during the COVID-19 pandemic and saw the two companies work together...
Explained: New COVID-19 variants FLiRT and LB.1, driving surge in US, UK
Indian Express· 9 hours agoWhat impact could these mutations have and what precautions should be taken? What do we know about...
Pfizer, Moderna Covid vaccine patents battle to continue after UK ruling
Business Standard India· 6 days agoPfizer and Moderna's legal battle over their rival Covid-19 vaccines looks set to continue after...
GSK to pay CureVac up to €1.4 billion for flu, COVID shots - CNBC TV18
CNBC TV18· 5 days agoGSK Plc agreed to pay as much as €1.4 billion ($1.5 billion) for the full rights to mRNA flu and ...
Coronavirus and COVID remain health threats. Get vaccinated this fall, CDC says.
Durham Herald-Sun· 7 days agoMandy Cohen, director of the CDC. “Make a plan now for you and your family to get both updated flu...
NIH announces start of subject enrolment for nasal Covid-19 vaccine trial
Clinical Trials Arena· 6 days agoClinic of Emory University in Georgia and New York University in New York. Each of these subjects...
UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case - ET LegalWorld
The Economic Times· 6 days agoCOVID Vaccine Patents: London's High Court on Tuesday ruled that one of Moderna's patents relating...
What to Know About the LB.1 COVID-19 Variant
Verywell Health· 5 days ago“There is no evidence today that the LB.1 variant is causing different or more severe symptoms compared to past variants. The real difference is on an...
Shelby Co ex-vaccine chief loses legal bid to clear her name after botched rollout
Tennessee Lookout· 3 days agoThe former leader of Shelby County’s COVID-19 vaccine rollout has lost a legal bid to declare she...